Medical Oncology

, Volume 12, Issue 4, pp 231–249

Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. I: Clinical applications and therapeutic effects

  • Thomas D. Miale
  • Suebsuk Sirithorn
  • Syed Ahmed
Review

Abstract

Here, we review the role of total body irradiation in the treatment of children with bone marrow transplantation, as well as alternative sources of stem cells. We were unable to demonstrate any clear superiority of TBI-containing preparative regimens, but we were able to find a few definitive reports of significantly enhanced toxicity or important variations in control of the underlying primary diseases, in comparing TBI-based regimens, with those containing only chemotherapy.

Keywords

bone marrow transplantation busulfan cyclophosphamide pediatrics stem cells total body irradiation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Martino, R., Badell, I., Brunet, S., Sureda, A., Torras, A., Cubells, J. and Domingo-Albos, A. (1995) High-dose busulfan and melphalan before bone marrow transplantation for acute nonlymphoblastic leukemia.Bone Marrow Transplant. 16, 209.PubMedGoogle Scholar
  2. 2.
    Sanders, J.E. (1994) Late effects after bone marrow transplant. In C.L. Schwartz, W.L. Hobbie, L.S. Constine and K.S. Ruccione (eds)Survivors of Childhood Cancer: Assessment and Management, chap. 15, pp. 293–318. St. Louis: Mosby.Google Scholar
  3. 3.
    Draper, G.J., Sanders, B.M. and Kingston, J.E. (1986) Second primary neoplasms with retinoblastoma.Br. J. Cancer 53, 661.PubMedGoogle Scholar
  4. 4.
    Sankaranarayanan, K. and Chakraborty, R. (1995) Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. I. Background.Radiat. Res. 143, 121.PubMedCrossRefGoogle Scholar
  5. 5.
    Moore, I.M.K., Packer, R.J., Karl, D. and Bleyer, W.A. (1994) Adverse effects of cancer treatment on the central nervous system. In C.L. Schwartz, W.L. Hobbie, L.S. Constine and K.S. Ruccione (eds)Survivors of Childhood Cancer: Assessment and Management, chap. 3, pp. 81–110. St. Louis: Mosby.Google Scholar
  6. 6.
    McCool, V. (1995) Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? In M.E. Trigg and F.L. Johnson (eds)Marrow Transplantation in Children: Current Results and Controversies, pp. 188–195. Meeting #2. Hilton Head Island, S C University of Iowa College of Medicine and University of Chicago Medical Center, Department of Pediatrics.Google Scholar
  7. 7.
    Gatti, R., Meerwissen, H., Allen, H., Hong, R. and Good, R. (1968) Immunological reconstirution of sex-linked lymphopenic immunological deficiency.Lancet 2, 1366.PubMedCrossRefGoogle Scholar
  8. 8.
    Bach, F.H., Albertini, R.J., Joo, P., Anderson, J.L. and Bortin, M.M. (1968) Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome.Lancet 2, 1364.PubMedCrossRefGoogle Scholar
  9. 9.
    Thomas, E., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H. and Buckner, C.D. (1975) Bone-marrow transplantation.N. Engl. J. Med. 292, 832.PubMedGoogle Scholar
  10. 10.
    Thomas, E.D., Buckner, C.D., Banaji, M., Clift, R.A., Fefer, A., Flournoy, N., Goodell, B.W., Hickman, R.O., Lerner, K.G., Neiman, P.E., Sale, G.E., Sanders, J.E., Singer, J., Stevens, M., Storb, R. and Weiden, P.L. (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic bone marrow transplantation.Blood 49, 511.PubMedGoogle Scholar
  11. 11.
    Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H.G., Burns, W.H., Elfenbein, G.J., Kaizer, H., Mellirus, D., Sensenbrenner, L.L., Stuart, R.K. and Yeager, A.M. (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.N. Engl. J. Med. 309, 1347.PubMedGoogle Scholar
  12. 12.
    Brodsky, I., Bulova, S. and Crilley, P. (1989) The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation.Cancer Invest. 7, 509.PubMedCrossRefGoogle Scholar
  13. 13.
    Tutschka, P.J., Copelan, E.A. and Klein, J.P. (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen.Blood 70, 1382.PubMedGoogle Scholar
  14. 14.
    Tutschka, P.J., Copelan, E.A. and Kapoor, N. (1989) Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.Transplant Proc. 21, 2952.PubMedGoogle Scholar
  15. 15.
    Tutschka, P.J., Copelan, E.A., Kapoor, N., Avalos, B.R. and Klein, J.P. (1991) Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6 year results of a single institution trial.Transplant Proc. 23, 1709.PubMedGoogle Scholar
  16. 16.
    Petersen, F. and Bearman, S. (1994) Preparative regimens and their toxicity. In S. Forman, K. Blume and E. Thomas (eds)Bone Marrow Transplantation. chap. 8, p. 79. Boston: Blackwell Scientific Publications.Google Scholar
  17. 17.
    Valls, A., Granena, A., Carreras, E., Ferrer, E. and Algara, M. (1989) Total body irradiation in bone marrow transplantation: fractionated vs. single dose. Acute toxicity and preliminary results.Bull Cancer 76, 797.PubMedGoogle Scholar
  18. 18.
    Kim, T.H., McGlave, P.B., Ramsay, N., Woods, W., Boström, B., Vercellotti, G., Hurd, D., Krivit, W., Nesbit, M., Haake, R., Kahn, F. and Kersey, J.M. (1990) Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission.Int. J. Rad. Oncol. Biol. Phys. 19, 889.Google Scholar
  19. 19.
    Socie, G., Devergie, A., Girinsky, T., Reiffers, J., Vernant, J.P., Le Bourgeois, J.P., Herve, P., Guyotat, D., Maraninchi, D., Rio, B., Michallet, M., Jouet, J.P., Milplied, N., Leblond, V., Pico, J., Attal, M., Belanger, C., Gluckman, E. and Cosset, J.M. (1991) Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. TheGroupe d’Etude des Greffes de Moelle Osseuse (GEGMO).Int. J. Rad. Oncol. Biol. Phys. 20, 397.Google Scholar
  20. 20.
    Blaise, D., Maraninchi, D., Archimbaud, E., Reiffers, J., Devergie, A., Jouet, J.P., Milpied, N., Attal, M., Michallet, M., Ifrah, N., Kuentz, M., Dauriac, C., Bordigioni, P., Gratecos, N., Guilhot, F., Guyotat, D., Gouvernet, J. and Gluckman, E. (1992) Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from theGroup D’Etude de la Greffe de Moelle Osseuse.Blood 79, 2578.PubMedGoogle Scholar
  21. 21.
    Michel, G., Gluckman, E., Esperou-Bourdeau, H., Reiffers, J., Pico, J.L., Bordigoni, P., Thuret, I., Blaise, D., Bernaudin, F., Jouet, J.P., Lemerle, S., Rubie, H., Milpied, N., Vannier, J.P., Demeocq, F., Troussard, X., Gratecos, N., Plouvier, E., Bergeron, C., Gardembas, M., Gouvernet, J. and Maraninchi, D. (1994) Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation a report from theSociete Francaise de Greffe de Moelle.J. Clin. Oncol. 12, 1217.PubMedGoogle Scholar
  22. 22.
    Ramsay, N.K.C. (1995) Bone marrow transplantation for acute lymphoblastic leukemia: Preparative regimens. In M.E. Trigg and F.L. Johnson (eds)Marrow Transplantation in Children: Current Results and Controversies, Meeting #2. Hilton Head Island, SC University of Iowa College of Medicine and University of Chicago Medical Center, pp. 103–105.Google Scholar
  23. 23.
    Ringdén, O., Ruutu, T., Remberger, M., Nikoskelainen, J., Volin, L., Vindelov, L., Parkkali, T., Lenhoff, S., Sallerfors, B., Ljungman, P., Mellander, L. and Jacobsen, N. (1994) A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.Blood 83, 2723.PubMedGoogle Scholar
  24. 24.
    Clift, R.A., Buckner, C.D., Thomas, E.D., Bensinger, W.I., Bowden, R., Bryant, E., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P. and Appelbaum, F.R. (1994) Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.Blood 84, 2036.PubMedGoogle Scholar
  25. 25.
    Dusenbery, K., Daniels, K., McClure, J., McGlave, P., Ramsay, N., Kersey, J. and Woods, W. (1994) Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia (abstr.).Proc ASCO. p. 310. Dallas TX: Saunders.Google Scholar
  26. 26.
    Beelen, D.W., Quabeck, K., Graeven, U., Sayer, H.G., Mahmoud, H.K. and Schaefer, U.W. (1989) Acute toxidty and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia.Blood 74, 1507.PubMedGoogle Scholar
  27. 27.
    Nevill, T.J., Barnett, M.J., Klingemann, H.G., Reece, D.E., Shepherd, J.D. and Phillips, G.L. (1991) Regimen-related toxidty of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation.J. Clin. Oncol. 9, 1224.PubMedGoogle Scholar
  28. 28.
    Phillips, G.L., Shepherd, J.D., Barnert, M.J., Lansdorp, P.M., Klingemann, H.G., Spinelli, J.J., Nevill, T.J., Chan, K.W. and Reece, D.E. (1991) Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.J. Clin. Oncol. 9, 1880.PubMedGoogle Scholar
  29. 29.
    Crilley, P., Topolsky, D., Bulova, S., Bigler, R. and Brodsky, I. (1990) Bone marrow transplantation following busulfan and cyclophosphamide for acute myelogenous leukemia.Bone Marrow Transplant. 5, 187.PubMedGoogle Scholar
  30. 30.
    Blume, K.G., Kopecky, K.J., Henslee-Downey, J.P., Forman, S.J., Stiff, P.J., LeMaistre, C.F. and Appelbaum, F.R. (1993) A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission; a Southwest Oncology Group study.Blood 81, 2187.PubMedGoogle Scholar
  31. 31.
    von Bueltzingsloewen, A., Bêlanger, R., Perreault, C., Bonny, Y., Roy, D.-C., Boileau, J., Kassis, J., LaVallée, R., Lacombe, M. and Gyger, M. (1993) Allogeneic bone marrow transplantation following busulfan-cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukemia.Br. J. Haematol. 85, 706.CrossRefGoogle Scholar
  32. 32.
    Snyder, D.S., Chao, N.J., Amylon, M.D., Taguchi, J., Long, G.D., Negrin, R.S., Nademanee, A.P., O’Donnell, M.R., Schmidt, G.M., Stein, A.S., Parker, P.M., Smith, E.P., Stephan, D.E., Molina, A., Lipsett, J.A., Hoppe, R.T., Niland, J.C., Dagis, A.C., Wong, R.M., Forman, S.J. and Blume, K.G. (1993) Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.Blood 82, 2920.PubMedGoogle Scholar
  33. 33.
    Pui, C.-H. and Crist, W.M. (1995) Treatment of childhood leukemias.Curr. Opinion Oncol. 7, 36.Google Scholar
  34. 34.
    Pui, C.-H. (1995) Medical progress: childhood leukemias.N. Engl. J. Med. 332, 1618.PubMedCrossRefGoogle Scholar
  35. 35.
    Pinkel, D. (1994) Role of bone marrow transplantation for acute lymphoid leukemia(letter).J. Pediatr. 125, 506.PubMedCrossRefGoogle Scholar
  36. 36.
    Lazarus, H.M. and Rowe, J.M. (1994) Bone marrow transplantation for acute lymphoblastic leukemia (ALL).Med. Oncol. 11, 75.PubMedCrossRefGoogle Scholar
  37. 37.
    Barrett, A.J., Horowitz, M.M., Pollock, B.H., Zhang, M.-J., Bortin, M.M., Buchanan, G.R., Camitta, B.M., Ochs, J., Graham-Pole, J., Rowlings, P.A., Rimm, A.A., Klein, J.P., Shuster, J.J., Sobocinski, K.A. and Gale R.P. (1994) Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.N. Engl. J. Med. 331, 1253.PubMedCrossRefGoogle Scholar
  38. 38.
    Davies, S.M., Shu, X.O., Wagner, J.E., Blazer, B.R., Weisdorf, D.J. and Ramsay, N.K.C. Unrelated donor bone marrow transplantation for acute leukemia in children (abstr. 1522).Blood 86, 383a.Google Scholar
  39. 39.
    Stockschläder, M., Hegewisch-Becker, S., Krüger, W., tom Dieck, A., Mross, K., Hoffknecht, M., Berger, C., Kohlschütter, B., Martin, H., Peters, S., Kabisch, H., Kuse, R., Weh, H. and Zander, A. (1995) Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.Bone Marrow Transplant. 16, 663.PubMedGoogle Scholar
  40. 40.
    Roberts, W.M., Rivera, G.K., Raimondt, S.C., Santana, V.M., Sandlund, J.T., Crist, W.M. and Pui, C.-H. (1994) Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukemia.Lancet 343, 331.PubMedCrossRefGoogle Scholar
  41. 41.
    Broniscer, A., Ribiero, R.C., Rivera, G.K., Raimondi, S.C., Hancock, H.L., Sandlund, J.T., Crist, W. and Pui, C.-H. (1995) Curability of Ph+ childhood acute lymphoblastic leukemia with intensive chemotherapy: prognostic importance of the initial white blood cell count (abstr. 692).Blood 86, 176a.Google Scholar
  42. 42.
    Feig, S., Harris, R. and Sather, H. (1995) Superiority of marrow transplantation to maintenance chemotherapy for childhood acute lymphoblastic leukemia in second com- plete remission (abstr. 1520).Blood 86, 383a.Google Scholar
  43. 43.
    Borgman, A., Schmidt, H., Hartmann, R., Baumgarten, E., Hermann, K., Klingbief, T., Ebell, W., Zintl, F., Gadner, H. and Henze, G. (1995) Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.Lancet 346, 873.CrossRefGoogle Scholar
  44. 44.
    Brenner, M.K. (1995) Autologous bone-marrow transplantation in childhood acute lymphoblastic leukaemia.Lancet 346, 856.PubMedCrossRefGoogle Scholar
  45. 45.
    Tepper, R.I. and Mule, J.I. (1994) Experimental and clinical studies of cytokine gene-modified tumor cells.Hum. Gene Ther. 5, 153.PubMedCrossRefGoogle Scholar
  46. 46.
    Shaw, P.J., Bergin, M.E., Burgess, M.A., Dalla Pozza, L., Kellie, S.J., Rowell, G., Stevens, M.M., Webster, B.H. and Bradstock, K.F. (1994) Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.J. Clin. Oncol. 12, 2138.PubMedGoogle Scholar
  47. 47.
    Gale, R.P., Horowitz, M.M., Weiner, R.S., Ash, R.C., Atkinson, K., Babu, R., Dicke, K.A., Klein, J.P., Lowenberg, B., Reiffers, J., Rimm, A.A., Rowlings, P.A., Sandberg, A.A., Sobocinski, K.A., Veum-Stone, J. and Bortin, M.M. (1995) Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission.Bone Marrow Transplant. 16, 203.PubMedGoogle Scholar
  48. 48.
    Amadori, S., Testi, A.M., Arićo, M., Comelli, A., Giuliano, M., Madon, E., Masera, G., Rondelli, R., Zanesco, L. and Mandelli, F. (1993) Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia.J. Clin. Oncol. 11, 1046.PubMedGoogle Scholar
  49. 49.
    Nesbit, M.E. Jr, Buckley, J.D., Feig, S.A., Anderson, J.P., Lamplin, B., Bernstein, I.D., Kim, T.H., Piomelli, S., Kersey, J.H., Coccia, P.H., O’Reilly, R.C., August, C., Thomas, E.D. and Hammond, G.D. (1994) Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.J. Clin. Oncol. 12, 127.PubMedGoogle Scholar
  50. 50.
    Zitoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., Caronia, F., Hayat, M., Dardenne, M., Vegna, M.L., Petti, M.C., Solbu, G. and Suciu, S. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia.N. Engl. J. Med. 332, 217.CrossRefGoogle Scholar
  51. 51.
    Clift, R.A., Buckner, C.D., Appelbaum, F.R., Schoch, G., Petersen, F.B., Bensinger, W.I., Sanders, J., Sullivan, K.M., Storb, R., Singer, J., Hansen, J.A. and Thomas, E.D. (1992) Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.J. Clin. Oncol. 10, 1723.PubMedGoogle Scholar
  52. 52.
    Appelbaum, F.R., Clift, R., Radich, J., Anasetti, C. and Buckner, C.D. (1995) Bone marrow transplantation for chronic myelogenous leukemia.Semin. Oncol. 22, 405.PubMedGoogle Scholar
  53. 53.
    Phillips, G.L., Nevill, T.J., Spinelli, J.J., Nantel, S.H., Klingemann, H.-G., Barnett, H.G., Shepherd, J.D., Chan, K.-W., Meharchand, J.M., Sutherland, H.J., Reece, D.E. and Messner, H.A. (1995) Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation.Bone Marrow Transplant. 15, 213.PubMedGoogle Scholar
  54. 54.
    Hansen, J.A., Gooley, T., Clift, R., Petersdorf, E.W., Martin, PJ. and Anasetti, C. (1995) Unrelated donor marrow transplants for patients with chronic myeloid leukemia (abstr. 479).Blood 86, 123a.Google Scholar
  55. 55.
    Gamis, A.S., Haake, R., McGlave, P. and Ramsay, N.K.C. (1993) Unrelated-donor bone marrow transplantation for Philadelphia-chromosome-positive chronic myelogenous leukemia in children.J. Clin. Oncol. 11, 834.PubMedGoogle Scholar
  56. 56.
    Cornish, J., Potter, M.N., Steward, C.G., Pamphilon, D., Greerf, A. and Oakhill, A. (1995) Unrelated donor bone marrow transplant for acute lymphoblastic leukemia in childhood (abstr. 1518).Blood 86, 382a.Google Scholar
  57. 57.
    Roy, J., McGlave, P.B., Filopovich, A.H., Miller, W.J., Blazar, B.R., Ramsay, N.K.C., Kersey, J.H. and Weisdorf, D.J. (1992) Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.Bone Marrow Transplant. 10, 77.PubMedGoogle Scholar
  58. 58.
    Heslop, H.E., Brenner, M.K. and Rooney, CM. (1994) Donor T cells as therapy for EBV lymphoproliferation post bone marrow transplant.N. Engl. J. Med. 330, 1185.CrossRefGoogle Scholar
  59. 59.
    Miller, J.S. and McGlave, P.B. (1993) Therapy for chronic myelogenous leukemia with marrow transplantation.Current Opinion Oncol. 5, 262.Google Scholar
  60. 60.
    Jones, R.J. and Bedi, A. (1994) Biology of chronic myeloid leukemia and its relevance to autologous bone marrow transplantation.Curr. Opinion Oncol. 6, 122.CrossRefGoogle Scholar
  61. 61.
    Broxmeyer, H.E. (1995) Cord blood as an alternative source for stem and progenitor cell transplantation.Curr. Opinion Pediatr. 7, 47.PubMedCrossRefGoogle Scholar
  62. 62.
    Broxmeyer, H.E. (1995) Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in transplantation.Transfusion 35, 694.PubMedCrossRefGoogle Scholar
  63. 63.
    Kurtzberg, J., Laughlin, M., Smith, C, Olsen, J., Graham, M.J., Stevens, C. and Rubenstein, P. (1995) Umbilical cord blood: an alternative source of hematopoietic stem cells for bone marrow reconstitution in unrelated donor transplantation(Abstr 1147).Blood 86, 290a.Google Scholar
  64. 64.
    Avalos, B.R., Klein, J.L., Kapoor, N., Tutschka, P.J., Klein, J.P. and Copelan, E.A. (1993) Preparation for marrow transplantation in Hodgkin’s and non-Hodgkin’s lympho-ma using Bu/CY.Bone Marrow Transplant. 12, 133.PubMedGoogle Scholar
  65. 65.
    Philip, T., Guglielmi, G., Hagenbeek, A., Somers, R., van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., Coiffer, B., Biron, P., Mandelli, F. and Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma.N. Engl. J. Med. 333, 1540.PubMedCrossRefGoogle Scholar
  66. 66.
    Madero, L., Munoz, A., Diaz de Heredia, A., Martinez, A., Badell, I., Esquembre, C, Ramirez, M., Otheo, E., Olive, A., Sastre, A., Pardo, N. and Castell, V. (1995) G-CSF after autologous bone marrow transplantation for malignant diseases in children.Bone Marrow Transplant. 15, 349.PubMedGoogle Scholar
  67. 67.
    Shank, B. (1994) Radiotherapeutic principles of bone marrow transplantation. In S.J. Forman, K.G. Blume and E.D. Thomas (eds)Bone Marrow Transplantation, chap. 9, pp. 96–113. Boston: Blackwell Scientific Publications.Google Scholar
  68. 68.
    Resbeut, M., Cowen, D., Blaise, D., Gluckman, E., Cosset, J.-M., Rio, B., Pene, F., Milpied, N., Cullére, J.-C., Reiffers, J. and Richaud, P. (1995) Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice?Int. J. Rad. Oncol. Biol. Phys. 31, 509.Google Scholar
  69. 69.
    Gale, R.P., Butturini, A. and Bortin, M.M. (1991) What does total body irradiation do in bone marrow transplants for leukemia?Int. J. Rad. Oncol. Biol Phys. 20, 631.Google Scholar
  70. 70.
    Gale, R.P., Butturini, A. and Bortin, M.M. (1991) Response to Vriesendorpet al. (letter).Int. J. Rad. Oncol. Biol. Phys. 20, 645.Google Scholar
  71. 71.
    Vriesendorp, H.M. (1991) Influence of radiation dose and radiation field size on the induction or treatment of leukemia.Sem. Hematol.,28, 25.Google Scholar
  72. 72.
    Vriesendorp, H.M., Johnson, P.M., Fey, T.H., McDonough, C.M., Zoetelief, J. and von Bekkum, D.W. (1985) Optimal dose of total body irradiation for allogeneic bone marrow transplantation.Transplant. Proc. 17, 517.Google Scholar
  73. 73.
    Vriesendorp, H.M. and van Bekkum, D.W. (1980) Role of total body irradiation in conditioning for bone marrow transplantation.Haematol Bluttransfus 25, 349.Google Scholar
  74. 74.
    Vriesendorp, H.M., Herman, M.G. and Saral, R. (1991) Future analyses of total body irradiation.Int. J. Rad. Oncol. Biol. Phys. 20, 635.Google Scholar
  75. 75.
    Hussein, S. and El-Khatib, E. (1995) Total body irradiation with a sweeping60Cobalt beam.Int. J. Rad. Oncol. Biol. Phys. 33, 493.Google Scholar
  76. 76.
    Frassoni, F. (1991) Eradication of leukaemic marrow and prevention of leukaemia relapse with total body irradiation and bone marrow transplantation.Med. Oncol. Tumor. Pharmacother. 8, 189.PubMedGoogle Scholar
  77. 77.
    Urban, C., Schwinger, W., Slavc, I., Schmid, C., Gamillscheg, A., Lackner, H., Hauer, C. and Pakisch, B. (1990) Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia.Bone Marrow Transplant. 5, 353.PubMedGoogle Scholar
  78. 78.
    Biggs, J.C, Atkinson, K., Avalos, B.R., Copelan, E.A., Criliey, P., Downs, K., Kapoor, N., Szer, J. and Tutschka, P. (1991) A multi-institutional study of Bu/Cy2 followed by allogeneic marrow transplantation in CML(abstr. 436).Exp. Hematol. 19, 572.Google Scholar
  79. 79.
    Devergie, A., Jouet, J.P., Guyotat, D., Blaise, D. and Attal, M. (1992) Is busulfan-cyclophosphamide regimen for transplant in chronic myeloid leukemia better than cyclo-phosphamide total body irradiation?(abstr. D311).J. Cell Biochem. Suppl16A, 195.Google Scholar
  80. 80.
    Elmongy, M.B., Shepherd, J.D., Barnett, M.J., Reece, D.E., Nantel, S.H., Klingemann, H.G. and Philips, G.L. (1992) Busulfan-cyclophosphamide conditioning and allogeneic bone marrow transplantation for chronic myelogenous leukemia(abstr. D314).J. Cell Biochem. Suppl16A, 196.Google Scholar
  81. 81.
    Miller, C., Wagner, J.E., Vogelsang, G.B. and Santos, G.W. (1991) A randomized trial of busulfan-cyclophosphamide versus cyclophosphamide-total body irradiation as preparative regimen for patients with chronic myelogenous leukemia (abstr. 1155).Blood 78, 291.Google Scholar
  82. 82.
    Santos, G.W. (1993) Busulfan and cyclophosphamide versus cyclophosphamide and total body irradiation for marrow transplantation in chronic myelogenous leukemia — a review.Leuk. Lymphoma 11 suppl 1, 201.PubMedGoogle Scholar
  83. 83.
    Vitale, V. and Franzone, P. (1991) The role of TBI in conditioning regimens for children.Bone Marrow Transplant. 7, 32.PubMedGoogle Scholar
  84. 84.
    Bacigalupo, A., Van Lint, M.T., Frassoni, F., Occhini, D., Gualandi, F., Lamparelli, T., Sogno, G., Tedone, E., Frassoni, F., Tong, J. and Marmont, A.M. (1991) Factors influencing remission post-BMT in patients with acute and chronic leukemia prepared with cyclophosphamide and total body irradiation (TBI).Bone Marrow Transplant. 7, 62.PubMedGoogle Scholar
  85. 85.
    Petersen, F.B., Deeg, H.J., Buckner, CD., Appelbaum, F.R., Storb, R., Clift, A., Sanders, J.E., Bensinger, W.I., Witherspoon, R.P., Sullivan, K.M., Doney, K. and Hansen, J.A. (1992) Marrow transplantation following escalating doses of fractionated total body irradiation and cyclo-phosphamide-A phase I trial.Int. J. Rad. Oncol Biol Phys. 23, 1027.Google Scholar
  86. 86.
    Miralbell, R., Chapuis, B., Nouet, P., Helg, C., Delorme, H., Wacker, P., Wyss, M. and Kurtz, J. (1993) Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graft.Bone Marrow Transplant. 11, 447.PubMedGoogle Scholar
  87. 87.
    Sierra, J., Granena, A., Garcia, J., Valls, A., Carreras, E., Rovira, M., Canals, C, Martinez, E., Punti, C., Algara, M., Marin, P., Merino, A., Terol, M.J., Urbano-Ispizua, A. and Rozman, C. (1993) Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients.Bone Marrow Transplant. 12, 517.PubMedGoogle Scholar
  88. 88.
    Moussalem, M., Esperou Bourdeau, H., Devergie, A., Baruchel, A., Ribaud, P., Socie, G., Parquet, N., Traineau, R., Hirsch, I., Schaison, G. and Gluckman, E. (1995) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.Bone Marrow Transplant. 15, 943.PubMedGoogle Scholar
  89. 89.
    Cony-Makhoul, P., Marit, G., Boiron, J.M., Puntous, M. and Reiffers, J. (1995) Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.Bone Marrow Transplant. 16, 69.PubMedGoogle Scholar
  90. 90.
    Appelbaum, F., Badger, C, Bernstein, I., Buckner, C., Deeg, H., Eary, J., Matthews, D., Press, O., Storb, R. and Thomas, E. (1992) Is there a better way to deliver total body irradiation?Bone Marrow Transplant. 10, 77.PubMedGoogle Scholar
  91. 91.
    Appelbaum, F., Matthews, D., Press, O., Eary, J., Martin, P., Fisher, D. and Bernstein, I. (1994) Targeted radiotherapy as a preparative regimen for marrow transplantation. In R.E. Champlin, M.M. Horowitz, J.H. Kersey, R.J. O’Reilly and R.S. Parkman (eds)Am. Soc. Blood and Marrow Transplant. 1st Mtg. p. 45. Keystone Colorado USA: Medical College of Wisconsin Press.Google Scholar
  92. 92.
    Matthews, D., Appelbaum, F., Eary, J., Fisher, D., Durack, L., Bush, S., Hui, E., Martin, P., Mitchell, D., Press, O., Badger, C., Storb, R., Nelp, W. and Bernstein, I. (1995) Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by131I-labelled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.Blood 85, 1122.PubMedGoogle Scholar
  93. 93.
    Wasserman, T.H. (1994) Radiotherapeutic studies with amifostine (Ethyol).Semin. Oncol. 21(Suppl 11), 21.PubMedGoogle Scholar
  94. 94.
    Douay, L., Hu, C., Giarratana, M.-C., Bouchet, S., Cordon, J., Capizzi, R.L. and Gorin, N.-C. (1995) Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.Blood 86, 2849.PubMedGoogle Scholar
  95. 95.
    Hanson, W.R. (1995) Eicosanoid-induced protection of normal tissue during cancer treatment to achieve therapeutic gain. In K.V. Honn, L.J. Marnett, P.Y.-K. Wong, R. Jones and S.S. Nigam (eds)Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury, p. 25. Hong Kong: Plenum Press.Google Scholar
  96. 96.
    Hanson, W.R., Zhen, W., Geng, L., Hunter, N. and Milas, L. (1995) The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumorsin vivo from radiation injury.Radiat. Res. 142, 281.PubMedCrossRefGoogle Scholar
  97. 97.
    May, C., Gunther, R. and McIvor, R.S. (1995) Protection of mice from lethal doses of methotrexate by transplantation of transgenic marrow expressing drug-resistant dihydrofolate reductase activity.Blood 86, 2439.PubMedGoogle Scholar
  98. 98.
    Gao, X. and Honn, K.V. (1995) 12-lipoxygenase and 12(S)-HETE in cancer invasion and metastasis.Adv. Oncol. 11, 3.Google Scholar
  99. 99.
    Bearman, S.I. (1995) The syndrome of hepatic veno-occlusive disease after marrow transplantation.Blood 85, 3005.PubMedGoogle Scholar
  100. 100.
    Bearman, S.I., Shen, D.D., Hinds, M.S., Hill, H.A. and McDonald, G.B. (1993) A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation.Br. J. Hæmatol. 84, 724.PubMedCrossRefGoogle Scholar
  101. 101.
    Zaffroni, N., Villa, R., Orlandi, L., De Pascale, A., Del Mastro, S. and Silvestrini, R. (1993) Differential effect of 9b-chloro-16,16-dimethyl prostaglandin E2 (nocloprost) on the radiation response of human normal fibroblasts and colon adenocarcinoma cells.Radiat. Res. 135, 88.CrossRefGoogle Scholar
  102. 102.
    Wong, G.H.W. (1995) Lymphotoxin and tumor necrosis factor radioprotect normal tissues but radiosensitize tumor cellsin vivo. In K.V. Honn, L.J. Marnett, P.Y.-K. Wong, R. Jones and S.S. Nigam (eds)Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury, p. 51. Hong Kong: Plenum Press, Inc.Google Scholar
  103. 103.
    Wong, G.H.W. (1995) Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD.Biochim. Biophys. Acta. 1271, 205.PubMedGoogle Scholar
  104. 104.
    Tutschka, P.J. (1993) Use of busulfan containing che- motherapy for conditioning patients with leukemia for bone marrow allografting.Bone Marrow Transplant. 12, 34.PubMedGoogle Scholar
  105. 105.
    Miniero, R. (1991) Allogeneic bone marrow transplantation in children with acute leukemia: TBI is it necessary?Bone Marrow Transplant. 7, 37.PubMedGoogle Scholar
  106. 106.
    Blume, K.G. and Forman, S.J. (1992) High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies.Sem. Oncol. 19, 63.Google Scholar
  107. 107.
    Blume, K.G., Long, G.D., Negrin, R.S., Chao, N.J., Kusnierz-Glaz, C. and Amylon, M.D. (1994) Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.Bone Marrow Transplant. 14 (Suppl. 4), S9.PubMedGoogle Scholar
  108. 108.
    Dann, E.J., Gillis, S. and Rowe, J.M. (1995) Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature.Leukemia 9, 1072.PubMedGoogle Scholar
  109. 109.
    Inoue, T., Ikeda, H., Yamazaki, H., Tang, J.T., Song, C., Teshima, T., Murayama, S., Ohtani, M., Shibata, H. and Masaoka, T. (1993) Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.Strahlenther. Onkol. 169, 250.PubMedGoogle Scholar
  110. 110.
    Ghany, A.M., Tutschka, P.J., McGhee, R.B.Jr, Avalos, B.R., Cunningham, I., Kapoor, N. and Copelan, E.A. (1991) Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy.Transplantation 52, 310.PubMedGoogle Scholar
  111. 111.
    Lynch, M.H.E., Petersen, F.B., Appelbaum, F.R., Bensinger, W.I., Clift, R.A., Storb, R., Sanders, J.E., Hansen, J.A. and Buckner, C.D. (1995) Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.Bone Marrow Transplant. 15, 59.PubMedGoogle Scholar
  112. 112.
    Yamaguchi, M., Nakao, S., Ueda, M., Takamatsu, H., Takaru, Y., Shiobara, S., Masauji, N., Matsue, K. and Matsuda, T. (1995) Early recovery of host-derived hematopoiesis in marrow transplant recipients conditioned with high-dose busulfan and cyclophosphamide.Bone Marrow Transplant. 15, 787.PubMedGoogle Scholar
  113. 113.
    Copelan, E.A., Biggs, J.C., Thompson, J.M., Crilley, P., Szer, J., Klein, J.P., Kapoor, N., Avalos, B.R., Cunningham, I., Atkinson, K., Downs, K., Harmon, G., Daly, M., Brodsky, I., Bulova, S. and Tutschka, P. (1991) Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2.Blood 78, 838.PubMedGoogle Scholar
  114. 114.
    Geller, R.B., Myers, S., Devine, S., Larson, R.A., Williams, S.F., Park, C.L., O’Toole, K., Chandler, C. and Topper, R.L. (1992) Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.Bone Marrow Transplant. 9, 41.PubMedGoogle Scholar
  115. 115.
    Dinndorf, P. and Bunin, N. (1995) Bone marrow transplantation for children with acute myelogenous leukemia.Am. J. Pediatr. Hematol. Oncol. 17, 211.CrossRefGoogle Scholar
  116. 116.
    Bureo, E., Ortega, J.J., Munoz, A., Cubells, J., Madero, L., Verdaguer, A., Baro, J., Olive, T., Maldonado, M.S., Pardo, N., Diaz, M.A. and Ferris, J. (1995) Bone marrow transplantation in 46 pediatric patients with non-Hodgkin’s lymphoma.Bone Marrow Transplant. 15, 353.PubMedGoogle Scholar
  117. 117.
    Gill, P.K., Harrington, W.J., Kaplan, M.H., Ribiero, R.C., Bennett, J.M., Liebman, H.A., Bernstein-Singer, M., Espina, B.M., Cabral, L., Allen, S., Kornblau, S., Pike, M.C. and Levine, A.M. (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.N. Engl. J. Med. 332, 1744.PubMedCrossRefGoogle Scholar
  118. 118.
    Gallo, R.C. (1995) A surprising advance in the treatment of viral leukemia.N. Engl. J. Med. 332, 1783.PubMedCrossRefGoogle Scholar
  119. 119.
    Henslee-Downey, P.J., (1995) Mismatched bone marrow transplantation.Curr. Opinion Oncol. 7, 115.CrossRefGoogle Scholar
  120. 120.
    Purdy, M.H. and Shpall, E.J. (1994) The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.Med. Oncol. 11, 47.PubMedCrossRefGoogle Scholar
  121. 121.
    Hong, D.-S. and Deeg, HJ. (1994) Hematopoietic stem cells: sources and applications.Med. Oncol. 11, 63.PubMedCrossRefGoogle Scholar
  122. 122.
    Santos, G.W. (1995) Bone marrow transplantation: editorial review.Curr. Opinion Oncol. 7, 101.CrossRefGoogle Scholar
  123. 123.
    Demuynck, H., Delforge, M., Zachée, P., Verhoef, G.E.G., Vandenberghe, P. and Boogaerts, M.A. (1995) An update on peripheral blood progenitor cell transplantation.Ann. Hematol. 71, 29.PubMedCrossRefGoogle Scholar
  124. 124.
    Azevedo, W.M., Aranha, F.J.P., Gouvea, J.V., Vigorito, A.C., Marques, Jr. J.F.C., Eid, K.A.B., Azevedo, A.M. and Souza, C.A. (1995) Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies.Bone Marrow Transplant. 16, 647.PubMedGoogle Scholar
  125. 125.
    Balduzzi, A., Gooley, T., Anasetti, C., Sanders, J.E., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Sullivan, K.M. and Hansen, J.A. (1994) Unrelated donor marrow transplantation in children (abstr. #1559).Blood 84 (Suppl 1), 393.Google Scholar
  126. 126.
    Wagner, J.E., Kernan, N.A., Steinbach, M., Broxmeyer, H.E. and Gluckman, E. (1995) Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease.Lancet 346, 214.PubMedCrossRefGoogle Scholar
  127. 127.
    Wagner, J.E. (1995) Umbilical cord blood transplantation.Transfusion 35, 619.PubMedCrossRefGoogle Scholar
  128. 128.
    Payne, T.A., Traycoff, C.M., Laver, J., Xu, F., Srour, E.F. and Abboud, M.R. (1995) Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.Bone Marrow Transplant. 15, 187.PubMedGoogle Scholar
  129. 129.
    Gluckman, E., Broxmeyer, H.E., Auerbach, A.D., Freidman, H.S., Douglas, G.W., Devergie, A., Esperov, H., Thierry, D., Socie, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J. and Boyse, E.A. (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means umbilical-cord blood from an HLA-identical sibling.N. Eng. J. Med. 321, 1174.Google Scholar
  130. 130.
    Issaragrisil, S., Visuthisakchai, S., Suvatte, V., Tanphaichitr, V.S., Chandanayingyong, D., Schreiner, T., Kanokpongsakdi, S., Siritanaratkul, N. and Piankijagum, A. (1995) Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia.N. Engl. J. Med. 332, 367.PubMedCrossRefGoogle Scholar
  131. 131.
    Barquinero, J., Witherspoon, R., Sanders, J., Horowitz, M.M., Mantuoro, A., Patton, D.F., Bacigalupa, A., Abecasis, M.M., Miale, T.D., Rozman, C., Bryant, E. and Storb, R. (1995) Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells.Br. J. Hæmatol. 90, 595.PubMedCrossRefGoogle Scholar
  132. 132.
    Jones, D.R.E., Anderson, E.M., Evans, A.A. and Liu, D.T.Y. (1995) Long-term storage of human fetal hematopoietic progenitor cells and their subsequent reconstitution. Implications forin utero transplantation.Bone Marrow Transplant. 16, 297.PubMedGoogle Scholar
  133. 133.
    Shing, M.M.K. and Vowels, M. (1993) Role of second bone marrow transplants.Bone Marrow Transplant. 12, 21.PubMedGoogle Scholar
  134. 134.
    Radich, J.P., Sanders, J.E., Buckner, C.D., Martin, P.J., Petersen, F.B., Bensinger, W., McDonald, G.B., Mori, M., Schoch, G. and Hansen, J.A. (1993) Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.J. Clin. Oncol. 11, 304.PubMedGoogle Scholar
  135. 135.
    Appelbaum, F.R., Clift, R., Buckner, C.D., Anasetti, C., Radich, J., Higano, T., Storb, R., Hansen, J. and Thomas, E.D. (1994) Allogeneic bone marrow transplantation for chronic myelogenous leukemia.Med. Oncol. 11, 69.CrossRefGoogle Scholar
  136. 136.
    Kolb, H.J., Mittermüller, J., Clemm, C.H., Holler, E., Ledderose, G., Brehm, G., Heim, M. and Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.Blood 76, 2462.PubMedGoogle Scholar
  137. 137.
    Helg, C., Roux, E., Beris, P., Cabrol, C., Wacker, P., Darellay, R., Wyss, M., Jeannet, M., Chapuis, B. and Roosnek, E. (1993) Adoptive immunotherapy for CML after BMT.Bone Marrow Transplant 12, 125.PubMedGoogle Scholar
  138. 138.
    Porter, D.L. and Antin, J.H. (1995) Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation.Leuk. Lymphoma 17, 191.PubMedCrossRefGoogle Scholar
  139. 139.
    van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Crosss, N.C.P., Chase, A., Garicochea, B., Bungey, J., Barrett, J. and Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse.Blood 83, 3377.PubMedGoogle Scholar
  140. 140.
    Mackinnon, S., Papadopoulos, E.P., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W. and O’Reilly, RJ. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia following bone marrow transplantation. Separation of graft-versus-leukemia responses from graft-versus-host disease.Blood 86, 1261.PubMedGoogle Scholar
  141. 141.
    Pigneux, A., Devergie, A., Pochitaloff, M., Rio, B., Archimbaud, E., Cahn, J.U., Leblond, V., Michallet, M., Jouet, J.P., Guilhot, F.E.G. and Reiffers, J. (1995) Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from theSociété Française de Greffe de Moelle.Bone Marrow Transplant. 15, 819.PubMedGoogle Scholar
  142. 142.
    Miale, T.D. and Kirpekar, K. (1994) Neuroblastoma stage IV-S.Med. Oncol. 11, 89.PubMedCrossRefGoogle Scholar
  143. 143.
    Moss, T.J., Reynolds, C.P., Sather, H.N., Romansky, S.G., Hammond, G.D. and Seeger, R.C. (1991) Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.N. Engl. J. Med. 324, 219.PubMedGoogle Scholar
  144. 144.
    Lam-Po-Tang, P.R.L., McCowage, G.B. and Vowels, M.R. (1993) Teniposide, doxorubicin, melphalan, cisplatin and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.Transplant. Proc. 25, 2881.PubMedGoogle Scholar
  145. 145.
    Emminger, W. and Gadner, H. (1992) Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatinum (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal rumor (letter).Pediatr. Hematol. Oncol. 9, 183.PubMedCrossRefGoogle Scholar
  146. 146.
    Philip, T., Ladenstein, R., Zucker, J.M., Pinkerton, R., Bouffet, E., Louis, D., Siegert, W., Bernard, J.L., Frappaz, D., Coze, C., Wyss, M., Beck, D., Soulliet, G., Michon, J., Philip, I., Chauvin, M. and Biron, P. (1993) Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma, the LMCE2 study.Br. J. Cancer 67, 119.PubMedGoogle Scholar
  147. 147.
    Matthay, K.K., Atkinson, J.B., Stram, D.O., Selch, M., Reynolds, C.P. and Seeger, R.C. (1993) Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Children’s Cancer Group pilot study.J. Clin. Oncol. 11, 2226.PubMedGoogle Scholar
  148. 148.
    Stine, K., Longee, D., Kietzel, M. and Becton, D. (1994) Autologous bone marrow transplant [ABMT] with unpurged marrow in children with neuroblastoma [NB] (abstr. 1460).Proc ASCO. 13, 426.Google Scholar
  149. 149.
    Gazitt, Y., He, Y.J., Rios, A., Koza, S., Fisk, D., Graham-Pole, J. and Gross, S. (1992) To purge or not to purge: the neuroblastoma experience.Prog. Clin. Biol. Res. 377, 643.PubMedGoogle Scholar
  150. 150.
    Horowitz, M.E., Kinsella, T.J., Wexler, L.H., Belasco, J., Triche, T., Tsokos, M., Steinberg, S.M., McCIure, L., Longo, D.L., Steis, R.G., Glatstein, E., Pizzo, P.A. and Miser, J.S. (1993) Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing’s sarcoma and rhabdomyosarcoma.J. Clin. Oncol. 11, 1911.PubMedGoogle Scholar
  151. 151.
    Meyers, P.A., Gardner, S., Lindsley, K., Leibel, S. and Kushner, B. (1995) High-risk Ewing’s sarcoma (ES)/primitive neuroectodermal tumor (PNET) of bone: consolidation with total body irradiation (TBI), melphalan, and autologous stem cell reconstitution. (abstr. 1447).Proc. ASCO. 14, 451.Google Scholar
  152. 152.
    Ladenstein, R., Lasset, C, Pinkerton, R., Zucker, J.M., Peters, C., Burdach, S., Pardo, N., Dollorso, G., Buclon, M., Philip, T. and Hartmann, O. (1995) Impact of megatherapy in children with high-risk Ewing’s tumors in complete remission: a report from the EBMT solid rumor registry.Bone Marrow Transplant. 15, 697.PubMedGoogle Scholar
  153. 153.
    Long, G.D., Negrin, R.S., Hoyle, C.F., Kusnierz-Glaz, C.R., Schriber, J.R., Blume, K.G. and Chao, N.J. (1995) Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies.Cancer 76, 860.PubMedCrossRefGoogle Scholar
  154. 154.
    Petersen, F.B., Buckner, C.D., Appelbaum, F.R., Sanders, J.E., Bensinger, W.I., Storb, R., Deeg, H.J., Witherspoon, R.P., Sullivan, K.M., Clift, R.A., Hansen, J.A. and Thomas, E.D. (1992) Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.Bone Marrow Transplant. 10, 83.PubMedGoogle Scholar
  155. 155.
    Yau, J.C., LeMaistre, C.F., Andersson, B.S., Huan, S.D., Wallerstein, R.O., Woo, S.Y., Spitzer, G., Spinolo, J.A., Spencer, V., Brunner, L.J., Dimopoulos, M.A., Jagannath, S., Giralt, S., Meneghetti, C.M., Dicke, K.A. and Deisseroth, A.B. (1992) Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation.Am. J. Hematol. 41, 40.PubMedCrossRefGoogle Scholar
  156. 156.
    Spitzer, T.R., Peters, C., Ortlieb, M., Tefft, M.C., Torrisi, J., Cahill, R., Gadner, H., Urban, C. and Deeg, H.J. (1994) Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children.Int. J. Rad. Oncol. Biol. Phys. 29, 39.Google Scholar
  157. 157.
    Spitzer, T.R., Cottler-Fox, M., Torristi, J., Cahill, R., Greenspan, A., Lynch, M. and Deeg, H.J. (1989) Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.Bone Marrow Transplant. 4, 559.PubMedGoogle Scholar
  158. 158.
    Crilley, P., Topolsky, D., Styler, M.J., Bernstein, E., Resnick, K., Mullaney, R., Bulova, S., Brodsky, I. and Marks, D.I. (1995) Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogeneic bone marrow transplantation.Bone Marrow Transplant. 15, 361.PubMedGoogle Scholar
  159. 159.
    Uderzo, C, Rondelli, R., Dini, G., Dallorso, S., Messina, C, Miniero, R., Locatelli, F., De Manzini, A., Pession, A., Balduzzi, A., Loscasciulli, A. and Masera, G. (1995) High-dose vincristine, fractionated total body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukæmia in second remission: a 7-year Italian multicentre study.Br. J. Hcematol. 89, 790.CrossRefGoogle Scholar
  160. 160.
    Gucalp, R., Sparano, J., Dutcher, J.P. and Wiernik, P.H. (1994) Introduction to bone marrow transplant symposium held at the Albert Einstein Cancer Center at Bronx, NY, USA, March 23 to 25, 1994.Med. Oncol. 11, 31.PubMedCrossRefGoogle Scholar
  161. 161.
    Villablanca, J.G., Khan, A.A., Avramis, I., Seeger, R.C., Matthay, K.K., Ramsay, N.K.C. and Reynolds, C.P. (1995) Phase I Trial of 13-cis-retinoic acid in children with neuro-blastoma following bone marrow transplantation.J. Clin. Oncol. 13, 894.PubMedGoogle Scholar
  162. 162.
    Benyunes, M.C., Highuchi, C, York, A., Lindgren, C., Thompson, J.A., Buckner, CD. and Fefer, A. (1995) Immunotherapy with interleukin 2 with or without lympho-kine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial.Bone Marrow Transplant. 16, 283.PubMedGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • Thomas D. Miale
    • 1
    • 2
    • 4
  • Suebsuk Sirithorn
    • 1
    • 3
  • Syed Ahmed
    • 2
  1. 1.Departments of PediatricsUniversity of Tennessee Medical CenterKnoxville
  2. 2.Departments of Pediatrics Intemal MedicineUniversity of Tennessee Medical CenterKnoxville
  3. 3.Department of PediatricsBhumibol Adulyadej Hospital, R.T.A.F.Bangkhen, BangkokThailand
  4. 4.Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry IIKarolinska InstitutetStockholmSweden

Personalised recommendations